FimmCyte ^None

FimmCyte is a biotechnology company that is developing a new treatment based on the immune system. The treatment has shown positive results in early preclinical studies. FimmCyte focuses on developing novel treatments for women's health and other diseases by reprogramming the immune system through biotechnological approaches. Further information about the company's products, competitors, financials, employees, and headquarters can be found on their website.